{"record_key":"moleculedx-inc","identifier":"moleculedx-inc","external_key":"636D81","title":"MoleculeDX Inc.","summary":null,"url":"https://inventions.pitt.edu/startups/moleculedx-inc","json_url":"https://inventions.pitt.edu/startups/moleculedx-inc.json","object_key":"startups","description":"MoleculeDX brings molecular testing and machine learning together to support earlier detection of hepatocellular carcinoma, the most common form of primary liver cancer. Its Fusion-detect blood test analyzes cancer-associated fusion transcripts in serum and uses a computational model to identify patterns associated with the disease. At-home blood collection through contracted partners helps make testing more accessible. [1]: https://www.moleculedx.com/\nA University of Pittsburgh spinout, MoleculeDX builds on research into the molecular signals released by liver cancers. The company operates a CLIA-certified, COLA-accredited clinical laboratory and provides a digital platform for ordering tests, coordinating collection and receiving results, connecting laboratory innovation with practical screening support. [2]: https://www.linkedin.com/company/moleculedx [3]: https://www.moleculedx.com/about/","attributes":[{"key":"website","label":"Website","values":["https://www.moleculedx.com/"]},{"key":"sector","label":"Sector","values":["Diagnostic"]},{"key":"therapeutic_areas","label":"Therapeutic Areas","values":["Oncology"]},{"key":"founders","label":"Founders","values":["Jian-Hua Luo"]}],"related":[]}